| Literature DB >> 27118636 |
Huimin Guo1, Jie Zhu1, Yonggui Tan1, Chuanfeng Li1, Zongyan Chen1, Shiqi Sun2, Guangqing Liu3.
Abstract
In this study, virus-like particles (VLPs) derived from rabbit hemorrhagic disease virus (RHDV) were evaluated for the development of a vaccine against RHDV infection. The VP60 gene was cloned and inserted into a pSMK expression vector containing a small ubiquitin-like modifier (SUMO) tag that can promote the soluble expression of heterologous proteins in Escherichia coli cells. After expression and purification of His-SUMO-VP60 and cleavage of the SUMO tag, we found that the RHDV VP60 protein had self-assembled into VLPs with a similar shape and smaller size compared with authentic RHDV capsid. Next, the antigenicity and immunogenicity of the VLPs were examined. The results showed that RHDV-specific responses were clearly induced in rabbits and that all rabbits in the VLP group survived while those in the negative control group died within 72 h post-infection. These results suggest that VLP-based RHDV could be a promising RHDV vaccine candidate.Entities:
Keywords: Rabbit hemorrhagic disease virus; VP60 gene; Vaccine; Virus-like particle
Mesh:
Substances:
Year: 2016 PMID: 27118636 DOI: 10.1016/j.antiviral.2016.04.011
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970